Role of cerebral blood flow in extreme breath holding

The role of cerebral blood flow (CBF) on a maximal breath-hold (BH) in ultra-elite divers was examined. Divers (n = 7) performed one control BH, and one BH following oral administration of the non-selective cyclooxygenase inhibitor indomethacin (1.2 mg/kg). Arterial blood gases and CBF were measured...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bain Anthony R., Ainslie Philip N., Hoiland Ryan L., Willie Chris K., MacLeod David B., Madden Dennis, Maslov Petra Zubin, Drviš Ivan, Dujić Željko
Formato: article
Lenguaje:EN
Publicado: De Gruyter 2016
Materias:
Acceso en línea:https://doaj.org/article/296363fd70bd484d8cc61d0c4ef821df
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:296363fd70bd484d8cc61d0c4ef821df
record_format dspace
spelling oai:doaj.org-article:296363fd70bd484d8cc61d0c4ef821df2021-12-05T14:11:04ZRole of cerebral blood flow in extreme breath holding2081-693610.1515/tnsci-2016-0003https://doaj.org/article/296363fd70bd484d8cc61d0c4ef821df2016-01-01T00:00:00Zhttps://doi.org/10.1515/tnsci-2016-0003https://doaj.org/toc/2081-6936The role of cerebral blood flow (CBF) on a maximal breath-hold (BH) in ultra-elite divers was examined. Divers (n = 7) performed one control BH, and one BH following oral administration of the non-selective cyclooxygenase inhibitor indomethacin (1.2 mg/kg). Arterial blood gases and CBF were measured prior to (baseline), and at BH termination. Compared to control, indomethacin reduced baseline CBF and cerebral delivery of oxygen (CDO2) by about 26% (p < 0.01). Indomethacin reduced maximal BH time from 339 ± 51 to 319 ± 57 seconds (p = 0.04). In both conditions, the CDO2 remained unchanged from baseline to the termination of apnea. At BH termination, arterial oxygen tension was higher following oral administration of indomethacin compared to control (4.05 ± 0.45 vs. 3.44 ± 0.32 kPa). The absolute increase in CBF from baseline to the termination of apnea was lower with indomethacin (p = 0.01). These findings indicate that the impact of CBF on maximal BH time is likely attributable to its influence on cerebral H+ washout, and therefore central chemoreceptive drive to breathe, rather than to CDO2.Bain Anthony R.Ainslie Philip N.Hoiland Ryan L.Willie Chris K.MacLeod David B.Madden DennisMaslov Petra ZubinDrviš IvanDujić ŽeljkoDe Gruyterarticleapneacerebral oxygen deliveryhypercapniahypoxiaindomethacinNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENTranslational Neuroscience, Vol 7, Iss 1, Pp 12-16 (2016)
institution DOAJ
collection DOAJ
language EN
topic apnea
cerebral oxygen delivery
hypercapnia
hypoxia
indomethacin
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle apnea
cerebral oxygen delivery
hypercapnia
hypoxia
indomethacin
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Bain Anthony R.
Ainslie Philip N.
Hoiland Ryan L.
Willie Chris K.
MacLeod David B.
Madden Dennis
Maslov Petra Zubin
Drviš Ivan
Dujić Željko
Role of cerebral blood flow in extreme breath holding
description The role of cerebral blood flow (CBF) on a maximal breath-hold (BH) in ultra-elite divers was examined. Divers (n = 7) performed one control BH, and one BH following oral administration of the non-selective cyclooxygenase inhibitor indomethacin (1.2 mg/kg). Arterial blood gases and CBF were measured prior to (baseline), and at BH termination. Compared to control, indomethacin reduced baseline CBF and cerebral delivery of oxygen (CDO2) by about 26% (p < 0.01). Indomethacin reduced maximal BH time from 339 ± 51 to 319 ± 57 seconds (p = 0.04). In both conditions, the CDO2 remained unchanged from baseline to the termination of apnea. At BH termination, arterial oxygen tension was higher following oral administration of indomethacin compared to control (4.05 ± 0.45 vs. 3.44 ± 0.32 kPa). The absolute increase in CBF from baseline to the termination of apnea was lower with indomethacin (p = 0.01). These findings indicate that the impact of CBF on maximal BH time is likely attributable to its influence on cerebral H+ washout, and therefore central chemoreceptive drive to breathe, rather than to CDO2.
format article
author Bain Anthony R.
Ainslie Philip N.
Hoiland Ryan L.
Willie Chris K.
MacLeod David B.
Madden Dennis
Maslov Petra Zubin
Drviš Ivan
Dujić Željko
author_facet Bain Anthony R.
Ainslie Philip N.
Hoiland Ryan L.
Willie Chris K.
MacLeod David B.
Madden Dennis
Maslov Petra Zubin
Drviš Ivan
Dujić Željko
author_sort Bain Anthony R.
title Role of cerebral blood flow in extreme breath holding
title_short Role of cerebral blood flow in extreme breath holding
title_full Role of cerebral blood flow in extreme breath holding
title_fullStr Role of cerebral blood flow in extreme breath holding
title_full_unstemmed Role of cerebral blood flow in extreme breath holding
title_sort role of cerebral blood flow in extreme breath holding
publisher De Gruyter
publishDate 2016
url https://doaj.org/article/296363fd70bd484d8cc61d0c4ef821df
work_keys_str_mv AT bainanthonyr roleofcerebralbloodflowinextremebreathholding
AT ainsliephilipn roleofcerebralbloodflowinextremebreathholding
AT hoilandryanl roleofcerebralbloodflowinextremebreathholding
AT williechrisk roleofcerebralbloodflowinextremebreathholding
AT macleoddavidb roleofcerebralbloodflowinextremebreathholding
AT maddendennis roleofcerebralbloodflowinextremebreathholding
AT maslovpetrazubin roleofcerebralbloodflowinextremebreathholding
AT drvisivan roleofcerebralbloodflowinextremebreathholding
AT dujiczeljko roleofcerebralbloodflowinextremebreathholding
_version_ 1718371410731073536